Healthcare provider profile · identity verified

Todd James China, M.D.

Internal Medicine · HONOLULU, HI · NPI 1376737494

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	594	184
Amlodipine Besylate	Amlodipine Besylate	426	129
Losartan Potassium	Losartan Potassium	380	119
Metformin Hcl	Metformin Hcl	260	78
Lisinopril	Lisinopril	242	70
Levothyroxine Sodium	Levothyroxine Sodium	185	51
Simvastatin	Simvastatin	176	51
Tamsulosin Hcl	Tamsulosin Hcl	174	54
Omeprazole	Omeprazole	166	52
Metoprolol Succinate	Metoprolol Succinate	143	50
Fluticasone Propionate	Fluticasone Propionate	140	66
Pantoprazole Sodium	Pantoprazole Sodium	128	36
Glipizide	Glipizide	121	34
Pravastatin Sodium	Pravastatin Sodium	109	39
Alendronate Sodium	Alendronate Sodium	107	40
Allopurinol	Allopurinol	98	31
Rosuvastatin Calcium	Rosuvastatin Calcium	89	32
Tramadol Hcl	Tramadol Hcl	88	27
Furosemide	Furosemide	82	31
Finasteride	Finasteride	78	23
Hydrochlorothiazide	Hydrochlorothiazide	76	28
Gabapentin	Gabapentin	75	30
Zolpidem Tartrate	Zolpidem Tartrate	73	16
Escitalopram Oxalate	Escitalopram Oxalate	72	19
Eliquis	Apixaban	71	20
Trazodone Hcl	Trazodone Hcl	66	19
Azithromycin	Azithromycin	65	56
Famotidine	Famotidine	58	26
Mirtazapine	Mirtazapine	58	24
Lovastatin	Lovastatin	56	20
Triamcinolone Acetonide	Triamcinolone Acetonide	55	34
Glipizide Er	Glipizide	52	14
Ezetimibe	Ezetimibe	50	suppressed
Carvedilol	Carvedilol	48	20
Januvia	Sitagliptin Phosphate	48	13
Celecoxib	Celecoxib	47	22
Ozempic	Semaglutide	47	12
Atenolol	Atenolol	45	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	26
Clopidogrel	Clopidogrel Bisulfate	41	14
Felodipine Er	Felodipine	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	13
Metformin Hcl Er	Metformin Hcl	39	15
Pioglitazone Hcl	Pioglitazone Hcl	39	15
Prednisone	Prednisone	39	27
Albuterol Sulfate Hfa	Albuterol Sulfate	38	21
Jardiance	Empagliflozin	38	11
Pregabalin	Pregabalin	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Trulicity	Dulaglutide	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Rybelsus	Semaglutide	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	suppressed
Mupirocin	Mupirocin	30	22
Potassium Chloride	Potassium Chloride	30	suppressed
Diazepam	Diazepam	29	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Ketoconazole	Ketoconazole	27	13
Synthroid	Levothyroxine Sodium	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	11
Meclizine Hcl	Meclizine Hcl	26	14
Raloxifene Hcl	Raloxifene Hcl	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Valsartan	Valsartan	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Naproxen	Naproxen	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Baclofen	Baclofen	19	suppressed
Colchicine	Colchicine	19	suppressed
Lactulose	Lactulose	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Methylprednisolone	Methylprednisolone	18	16
Nystatin	Nystatin	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Estradiol	Estradiol	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Febuxostat	Febuxostat	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Donepezil Hcl	Donepezil Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Nystop	Nystatin	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Proctofoam-Hc	Hydrocortisone/Pramoxine	11	suppressed
Prolia	Denosumab	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error